InflamCorrelation between interleukin-23 receptor gene polymorphisms and risk of hepatitis B virus infection in patients

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 613-620

  Peng, Qiliu ^a   Qin, Yanping ^a,b   Chen, Zhiping ^c   Deng, Yan ^a   Xu, Juanjuan ^a   Li, Shan ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b Department of Clinical Laboratory   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; Hepatocellular carcinoma; Interleukin 23 receptor; Liver cirrhosis; Polymorphism

Indexed keywords

INTERLEUKIN 23 RECEPTOR; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK; YOUNG ADULT;

HEPATITIS B VIRUS;

ADULT; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN; RISK; YOUNG ADULT;

EID: 84879934941     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1558     Document Type: Article

References (31)

1. Wang JS, Huang T, Su J, et al: Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 10: 143-146, 2001.
2. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ and Henderson BE: Hepatitis B virus, aflatoxins and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 49: 2506-2509, 1989.
3. Tao P, Zhi-Ming L, Tang-Wei L, et al: Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations. Dig Dis Sci 50: 525-532, 2005.
4. Zemel R, Issachar A and Tur-Kaspa R: The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis 15: 261-279, 2011.
5. Oppmann B, Lesley R, Blom B, et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725, 2000.
6. Abraham C and Cho J: Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15: 1090-1100, 2009.
7. Jiang Z, Yang P, Hou S, et al: IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 69: 1325-1328, 2010.
8. Duerr RH, Taylor KD, Brant SR, et al: A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science 314: 1461-1463, 2006.
9. Venegas M, Beltrán CJ, Alvarez L, et al: IL-23R Arg381Gln polymorphism in Chilean patients with inflammatory bowel disease. Eur Cytokine Netw 19: 190-195, 2008.
10. Wu Y, Lu Z, Chen Y, Xue F, Chen X and Zheng J: Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population. Hum Immunol 71: 1255-1258, 2010.
11. Illes Z, Safrany E, Peterfalvi A, et al: 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 431: 36-38, 2008.
12. Chen J, Lu Y, Zhang H, et al: A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol Carcinog 49: 862-868, 2010.
13. Chen B, Zeng Z, Xu L, et al: IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a case-control study. Cancer Epidemiol 35: 165-169, 2011.
14. Chu H, Cao W, Chen W, et al: Potentially functional polymorphisms in IL-23 receptor and risk of esophageal cancer in a Chinese population. Int J Cancer 130: 1093-1097, 2012.
15. Poole EM, Curtin K, Hsu L, et al: Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. Cancer Epidemiol 36: e104-e110, 2012.
16. Chien MH, Hsin CH, Chou LS, et al: Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility. Head Neck 34: 551-556, 2012.
17. Martin M and Herceg Z: From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med 4: 8, 2012.
18. Shi YY and He L: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction and genetic association at polymorphism loci. Cell Res 15: 97-98, 2005.
19. Stephens M, Smith NJ and Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989, 2001.
20. Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama K, Ban Y and Hirano T: Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 42: 126-130, 2009.
21. Kim ES, Kim SW, Moon CM, et al: Interactions between IL17A, IL23R and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population. Life Sci 90: 740-746, 2012.
22. Faragó B, Magyari L, Sáfrány E, et al: Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis 67: 248-250, 2008.
23. Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ and Morgan AR: IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population. Gastroenterol Res Pract 2010: 539461, 2010.
24. Liao R, Sun TW, Yi Y, et al: Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Sci 103: 984-992, 2012.
25. Szabo G and Lippai D: Molecular hepatic carcinogenesis: impact of inflammation. Dig Dis 30: 243-248, 2012.
26. Qin LX: Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma. Cancer Microenviron 5: 203-209, 2012.
27. McGeachy MJ, Chen Y, Tato CM, et al: The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10: 314-324, 2009.
28. Langowski JL, Zhang X, Wu L, et al: IL-23 promotes tumour incidence and growth. Nature 442: 461-465, 2006.
29. Zhang Z, Zhou B, Zhang J, et al: Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer. Cancer Genet Cytogenet 196: 146-152, 2010.
30. Mancini G, Kan SH and Gallagher G: A novel insertion variant of the human IL-23 receptor-alpha chain transcript. Genes Immun 9: 566-569, 2008.
31. Seng KC and Seng CK: The success of the genome-wide association approach: a brief story of a long struggle. Eur J Hum Genet 16: 554-564, 2008.